Bresolin, S
222  results:
Search for persons X
?
1

Collagen VI sustains cell stemness and chemotherapy resista..:

Cescon M ; Rampazzo E ; Bresolin S...
info:eu-repo/semantics/altIdentifier/pmid/37505240.  , 2023
 
?
 
?
4

Central nervous system involvement in childhood acute lymph..:

Cousins, A ; Olivares, O ; Markert, E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712090/.  , 2022
 
?
5

Customized bioreactor enables the production of 3D diaphrag..:

Maghin E ; Carraro E ; Boso D...
info:eu-repo/semantics/altIdentifier/pmid/35468920.  , 2022
 
?
6

Ruxolitinib as a novel therapeutic option for poor prognosi..:

Veltri G ; Silvestri C ; Gallingani I...
info:eu-repo/semantics/altIdentifier/pmid/34359628.  , 2021
 
?
7

Case Report: Intestinal Nodular Lymphoid Hyperplasia as Fir..:

Marzollo A ; Bresolin S ; Colavito D...
info:eu-repo/semantics/altIdentifier/pmid/34692603.  , 2021
 
?
8

Ruxolitinib as a novel therapeutic option for poor prognosi..:

Veltri G ; Silvestri C ; Gallingani I...
info:eu-repo/semantics/altIdentifier/pmid/34359628.  , 2021
 
?
9

Pro-inflammatory cytokines favor the emergence of ETV6-RUNX..:

Beneforti L ; Dander E ; Bresolin S...
info:eu-repo/semantics/altIdentifier/pmid/32118299.  , 2020
 
?
10

SYK targeting represents a potential therapeutic option for..:

Serafin V ; Porcu E ; Cortese G...
info:eu-repo/semantics/altIdentifier/pmid/31817853.  , 2019
 
?
11

HIF-1α/Wnt signaling-dependent control of gene transcriptio..:

Boso D ; Rampazzo E ; Zanon C...
info:eu-repo/semantics/altIdentifier/pmid/31410187.  , 2019
 
?
12

ActivinA: a new leukemia-promoting factor conferring migrat..:

Portale F ; Cricri G ; Bresolin S...
info:eu-repo/semantics/altIdentifier/pmid/30262563.  , 2019
 
?
13

SYK targeting represents a potential therapeutic option for..:

Serafin V ; Porcu E ; Cortese G...
info:eu-repo/semantics/altIdentifier/pmid/31817853.  , 2019
 
?
 
?
 
1-15